United States Antimony (NYSE:UAMY) Stock Price Up 7.4% – Still a Buy?

United States Antimony Co. (NYSE:UAMY) rose 7.4% on Monday . The stock traded as high as $10.56 and last traded at $10.4560. Approximately 3,759,112 shares traded hands during trading, a decline of 72% from the average daily volume of 13,658,303 shares. The stock had previously closed at $9.74.

Wall Street Analysts Forecast Growth

UAMY has been the topic of several analyst reports. B. Riley Financial lifted their target price on United States Antimony from $9.00 to $11.00 and gave the company a “buy” rating in a research report on Tuesday, February 24th. HC Wainwright lifted their target price on United States Antimony from $10.25 to $11.50 and gave the company a “buy” rating in a research report on Monday, March 23rd. Alliance Global Partners restated a “buy” rating on shares of United States Antimony in a research report on Wednesday, February 11th. Finally, Weiss Ratings initiated coverage on United States Antimony in a research report on Friday, March 20th. They issued a “sell (d-)” rating on the stock. Five equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $9.17.

United States Antimony Price Performance

The company has a 50-day moving average price of $9.33 and a 200 day moving average price of $8.36. The firm has a market capitalization of $1.43 billion, a PE ratio of -199.30 and a beta of 0.10.

United States Antimony (NYSE:UAMY) last announced its quarterly earnings data on Thursday, March 19th. The company reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01). The business had revenue of $13.03 million for the quarter, compared to the consensus estimate of $11.75 million. United States Antimony had a negative return on equity of 6.14% and a negative net margin of 11.05%. As a group, research analysts anticipate that United States Antimony Co. will post 0.03 earnings per share for the current year.

Institutional Investors Weigh In On United States Antimony

Hedge funds have recently made changes to their positions in the company. CoreCap Advisors LLC purchased a new stake in shares of United States Antimony in the fourth quarter worth about $27,000. Raymond James Financial Inc. purchased a new stake in shares of United States Antimony in the second quarter worth about $33,000. Meeder Asset Management Inc. purchased a new stake in shares of United States Antimony in the fourth quarter worth about $35,000. Harbour Investments Inc. lifted its position in shares of United States Antimony by 106.2% in the fourth quarter. Harbour Investments Inc. now owns 7,962 shares of the company’s stock worth $40,000 after buying an additional 4,101 shares in the last quarter. Finally, Geneos Wealth Management Inc. purchased a new stake in shares of United States Antimony in the third quarter worth about $49,000. 9.49% of the stock is currently owned by hedge funds and other institutional investors.

United States Antimony Company Profile

United States Antimony Corporation is a specialized mining and chemical company focused primarily on the production and processing of antimony and antimony-based compounds. The company operates its own extraction and milling facilities to recover antimony metal and antimony trioxide, which serve as critical raw materials in industries such as flame retardants for plastics and textiles, catalysts for chemical processes, and additives for glass and ceramics. In addition to antimony, United States Antimony maintains smaller-scale gold and silver operations in Mexico that provide supplementary revenue streams and diversification of its mineral portfolio.

Founded in the mid-20th century, United States Antimony has evolved from a single‐mine operator into a multinational enterprise with mining and processing sites in both the United States and Mexico.